Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Thomas McFall(Salk Institute for Biological Studies), Edward C. Stites(Salk Institute for Biological Studies)
npj Precision Oncology
November 23, 2022
Cited by 16


Related Papers